CITIUS ONCOLOGY, INC. - 8-K Filing
Citius Oncology reports positive health-related quality of life data for LYMPHIR in pivotal Study 302 presented at EORTC-CLTG 2026 Annual Meeting. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $CTOR
Read the full article at SEC EDGAR
Part of the story Zeo ScientifiX, Inc. - 8-K Filing (3 articles)